Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03019367 · ClinicalTrials.gov registry record · NA

Premature Infants Receiving Milking or Delayed Cord Clamping: PREMOD2

A NA study, sponsored by Sharp HealthCare.

Completed
Registry status
NA
Development phase
1,201
Enrollment target

NCT03019367: Completed NA study, sponsored by Sharp HealthCare.

NCT03019367 is a NA study that has completed, run by Sharp HealthCare. The registered enrollment target is 1,201 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03019367, a NA study, has completed, sponsored by Sharp HealthCare.

COMPLETED
Registry status
NA
Development phase
1,201 participants
Enrollment target

Study Summary

This study is being done to find out whether umbilical cord milking (UCM) is at least as good as or better than delayed cord clamping (DCC) to reduce bleeding in the brain or prevent death in premature newborns. The investigators will study short and long term outcomes of infants delivered before 32 weeks gestation that receive either UCM or DCC. \* The trial was stopped by the DSMB for safety in the small strata. They subsequently allowed for continuation of the trial in infants 29-32+6 wk GA.

Primary Outcome

Severe intraventricular hemorrhage of grade 3 or 4 or death

Interventions

  • PROCEDURE Umbilical cord milking UCM
  • PROCEDURE Delayed cord clamping DCC

Trial Details

FieldValue
Enrollment Target 1,201 participants
Start Date 2017-06-06
Est. Completion 2022-09-16
Phase NA
Sharp HealthCare

32 total trials

What the finished NCT03019367 record still lists

NCT03019367 is an interventional study that assigns participants to a tested intervention. Its 1,201 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% lower).

The record links to 0 conditions, and to 2 interventions - of which Umbilical cord milking UCM is the first listed.

NCT03019367 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03019367 about?

NCT03019367 is a clinical study titled "Premature Infants Receiving Milking or Delayed Cord Clamping: PREMOD2". This study is being done to find out whether umbilical cord milking (UCM) is at least as good as or better than delayed cord clamping (DCC) to reduce bleeding in the brain or prevent death in premature newborns. The investigators will study short and long term outcomes of infants delivered before 32...

What is the current status of trial NCT03019367?

This trial is currently completed. It is a NA study. The enrollment target is 1,201 participants. The study started on 2017-06-06. Estimated completion is 2022-09-16.

What interventions are being tested in trial NCT03019367?

The interventions under investigation include: Umbilical cord milking UCM (PROCEDURE), Delayed cord clamping DCC (PROCEDURE).

Who is sponsoring clinical trial NCT03019367?

This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03019367's enrollment target sits among peer trials

1,201 83rd of 2000 higher than 1,918 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001987 · 1,200 participants

    Genetic Studies of Insulin and Diabetes

  • NCT00477100 · 1,200 participants

    Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

  • NCT01209000 · 1,200 participants

    Nephrotic Syndrome Study Network

  • NCT01944332 · 1,200 participants · NA

    Gamete Treatment to Correct Fertilization Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03019367, the US trial registry maintained by the National Library of Medicine. NCT03019367 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.